AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 161 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $390 | -8.0% | 15,770 | +5.3% | 0.00% | 0.0% |
| Q2 2023 | $424 | +21.1% | 14,982 | -1.7% | 0.00% | +50.0% |
| Q1 2023 | $350 | -16.5% | 15,235 | +2.2% | 0.00% | -33.3% |
| Q4 2022 | $419 | -99.9% | 14,914 | -7.2% | 0.00% | 0.0% |
| Q3 2022 | $454,000 | +54.9% | 16,063 | +59.5% | 0.00% | +200.0% |
| Q1 2022 | $293,000 | -12.3% | 10,068 | -0.9% | 0.00% | 0.0% |
| Q4 2021 | $334,000 | -17.5% | 10,157 | +15.7% | 0.00% | -50.0% |
| Q3 2021 | $405,000 | -10.0% | 8,779 | +7.5% | 0.00% | 0.0% |
| Q2 2021 | $450,000 | +25.3% | 8,168 | +17.6% | 0.00% | 0.0% |
| Q1 2021 | $359,000 | +45.3% | 6,948 | +22.0% | 0.00% | +100.0% |
| Q4 2020 | $247,000 | -47.6% | 5,697 | -6.6% | 0.00% | -66.7% |
| Q3 2018 | $471,000 | -46.5% | 6,101 | -41.7% | 0.00% | -50.0% |
| Q2 2018 | $881,000 | -3.2% | 10,462 | -6.0% | 0.01% | 0.0% |
| Q1 2018 | $910,000 | +13.5% | 11,125 | -20.7% | 0.01% | +20.0% |
| Q4 2017 | $802,000 | +256.4% | 14,027 | +316.2% | 0.01% | +400.0% |
| Q3 2017 | $225,000 | +37.2% | 3,370 | -14.1% | 0.00% | 0.0% |
| Q2 2016 | $164,000 | +45.1% | 3,921 | +40.8% | 0.00% | 0.0% |
| Q1 2016 | $113,000 | -18.1% | 2,785 | +30.8% | 0.00% | 0.0% |
| Q4 2015 | $138,000 | -28.9% | 2,129 | -22.5% | 0.00% | -50.0% |
| Q3 2015 | $194,000 | +104.2% | 2,748 | +220.3% | 0.00% | +100.0% |
| Q2 2015 | $95,000 | +50.8% | 858 | +28.4% | 0.00% | – |
| Q1 2015 | $63,000 | +18.9% | 668 | +42.1% | 0.00% | – |
| Q4 2014 | $53,000 | +60.6% | 470 | -13.0% | 0.00% | – |
| Q3 2014 | $33,000 | +32.0% | 540 | -1.8% | 0.00% | – |
| Q2 2014 | $25,000 | +108.3% | 550 | +85.2% | 0.00% | – |
| Q1 2014 | $12,000 | +71.4% | 297 | +2.8% | 0.00% | – |
| Q4 2013 | $7,000 | – | 289 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |